Watson Pharmaceuticals (WPI +6.6%) gets a lift today after agreeing to acquire Swiss rival Actavis. The purchase gives the company a boost in the global rankings of generic drug makers to the number 3 spot. Citigroup upgrades the stock to Buy on the news.